Attached files

================================================================================

                                                                    EXHIBIT 32.1

                                 CERTIFICATION
                                  PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of Arkson Neutraceuticals, Inc. (the
"Company") on Form 10-K for the year ended June 30, 2009, as filed with the
Securities and Exchange Commission on the date hereof (the "Periodic Report"),
I, David Roff, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

1.    the Periodic Report fully complies with the requirements of Section 13(a)
      or 15(d) of the Securities Exchange Act of 1934; and

2.    the information contained in the Periodic Report fairly presents, in all
      material respects, the financial condition and results of operations of
      the Company.


Dated: August 26, 2010


/s/ "David Roff"


David Roff
Chief Executive Officer and Chief Financial Officer



-------------------------------------------------------------------------------